MRNA
Moderna, Inc.
NASDAQ · Healthcare · Biotechnology · US
$258.38
+13.11%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 47.19x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 15.26x
- Price / sales
- 46.30x
- Price / cash flow
- -98.06x
Enterprise value
- Enterprise value
- $99.3B
- EV / sales
- 44.57x
- EV / EBITDA
- -35.10x
- EV / EBIT
- -29.91x
- Market cap
- $103.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026